BDC Capital completed the acquisition of a minority stake in Genacol.

BDC Capital, a private equity firm, completed the acquisition of a minority stake in Genacol, a nutrition supplement retailer. Financial terms were not disclosed. “We are extremely proud to be able to count on the support of a quality financial partner such as BDC Capital to help us pursue our long-term growth plan both in Canada and on international markets. BDC Capital has taken note of the significant growth we have posted in recent years and has agreed to invest in our growth strategy, which is very promising for the future of the Genacol brand in the long term," Martin Vidal, Genacol President and CEO.